French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
데이터 추가 비고
조치
Lots N0610819 (per.05.03) and N1113325 (per.10.03) of the in vitro diagnostic medical device called COAMATIC Héparine - reference 823393 from Chromogénix, distributed in France by BIOGENIC, are withdrawn from the French market following reports This device allows the determination of unfractionated heparin or low molecular weight heparin in human plasma by automated or microplate technique.